Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity
NCT00120055
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Myopathy
Interventions
DRUG:
Atorvastatin (Lipitor)
Sponsor
University of Oslo School of Pharmacy